Literature DB >> 18683816

The impact of tyrosine kinase 2 (Tyk2) on the proteome of murine macrophages and their response to lipopolysaccharide (LPS).

Marta Radwan1, Ingrid Miller, Tom Grunert, Martina Marchetti-Deschmann, Claus Vogl, Niaobh O'Donoghue, Michael J Dunn, Thomas Kolbe, Günter Allmaier, Manfred Gemeiner, Mathias Müller, Birgit Strobl.   

Abstract

Tyrosine kinase 2 (Tyk2) belongs to the Janus kinase (Jak) family and is involved in signalling via a number of cytokines. Tyk2-deficient mice are highly resistant to lipopolysaccharide (LPS)-induced endotoxin shock. Macrophages are key players in the pathogenesis of endotoxin shock and, accordingly, defects in the LPS responses of Tyk2(-/-) macrophages have been reported. In the present study, the molecular role of Tyk2 is investigated in more detail using a proteomics approach. 2-D DIGE was applied to compare protein patterns from wild-type and Tyk2(-/-) macrophages and revealed significant differences in protein expression patterns between the genotypes before and after LPS treatment. Twenty-one proteins deriving from 25 differentially expressed spots were identified by MALDI/ESI MS. Among them, we show for N-myc interactor that its mRNA transcription/stability is positively influenced by Tyk2. In contrast, LPS-induced expression of plasminogen activator 2 protein but not mRNA is strongly enhanced in the absence of Tyk2. Our data furthermore suggest an influence of Tyk2 on the subcellular distribution of elongation factor 2 and on LPS-mediated changes in the peroxiredoxin 1 spot pattern. Thus, our results imply regulatory roles of Tyk2 at multiple levels and establish novel connections between Tyk2 and several cellular proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18683816     DOI: 10.1002/pmic.200800260

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  6 in total

1.  Tyrosine kinase 2 controls IL-1ß production at the translational level.

Authors:  Marta Radwan; Rita Stiefvater; Tom Grunert; Omar Sharif; Ingrid Miller; Martina Marchetti-Deschmann; Günter Allmaier; Manfred Gemeiner; Sylvia Knapp; Pavel Kovarik; Mathias Müller; Birgit Strobl
Journal:  J Immunol       Date:  2010-08-16       Impact factor: 5.422

2.  Transcriptome analysis reveals a major impact of JAK protein tyrosine kinase 2 (Tyk2) on the expression of interferon-responsive and metabolic genes.

Authors:  Claus Vogl; Thomas Flatt; Bernd Fuhrmann; Elisabeth Hofmann; Barbara Wallner; Rita Stiefvater; Pavel Kovarik; Birgit Strobl; Mathias Müller
Journal:  BMC Genomics       Date:  2010-03-25       Impact factor: 3.969

3.  Tyrosine kinase 2 promotes sepsis-associated lethality by facilitating production of interleukin-27.

Authors:  Markus Bosmann; Birgit Strobl; Nadia Kichler; Doris Rigler; Jamison J Grailer; Florence Pache; Peter J Murray; Mathias Müller; Peter A Ward
Journal:  J Leukoc Biol       Date:  2014-03-06       Impact factor: 4.962

4.  A comparative proteome analysis links tyrosine kinase 2 (Tyk2) to the regulation of cellular glucose and lipid metabolism in response to poly(I:C).

Authors:  Tom Grunert; Nicole R Leitner; Martina Marchetti-Deschmann; Ingrid Miller; Barbara Wallner; Marta Radwan; Claus Vogl; Thomas Kolbe; Dagmar Kratky; Manfred Gemeiner; Günter Allmaier; Mathias Müller; Birgit Strobl
Journal:  J Proteomics       Date:  2011-07-23       Impact factor: 4.044

5.  Bordetella pertussis Isolates from Argentinean Whooping Cough Patients Display Enhanced Biofilm Formation Capacity Compared to Tohama I Reference Strain.

Authors:  Laura Arnal; Tom Grunert; Natalia Cattelan; Daan de Gouw; María I Villalba; Diego O Serra; Frits R Mooi; Monika Ehling-Schulz; Osvaldo M Yantorno
Journal:  Front Microbiol       Date:  2015-12-08       Impact factor: 5.640

Review 6.  TYK2: An Upstream Kinase of STATs in Cancer.

Authors:  Katharina Wöss; Natalija Simonović; Birgit Strobl; Sabine Macho-Maschler; Mathias Müller
Journal:  Cancers (Basel)       Date:  2019-11-05       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.